Search research articles
Contact Us
Filters
Showing results (71-80 of 84) with videos related to
Page
of 9
Sort By:
JCI Insight
|
July 27, 2018
Extreme erythrocyte macrocytic and microcytic percentages are highly predictive of morbidity and mortality
Benjamin D Horne, Joseph B Muhlestein, Sterling T Bennett, et al.
Circulation. Heart Failure
|
November 3, 2009
An alpha2C-adrenergic receptor polymorphism alters the norepinephrine-lowering effects and therapeutic response of the beta-blocker bucindolol in chronic heart failure
Michael R Bristow, Guinevere A Murphy, Heidi Krause-Steinrauf, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
October 19, 2011
The intermountain risk score predicts incremental age-specific long-term survival and life expectancy
Benjamin D Horne, Joseph B Muhlestein, Donald L Lappé, et al.
Circulation
|
March 21, 2012
A randomized and clinical effectiveness trial comparing two pharmacogenetic algorithms and standard care for individualizing warfarin dosing (CoumaGen-II)
Jeffrey L Anderson, Benjamin D Horne, Scott M Stevens, et al.
BMJ Open
|
March 25, 2022
Association of the Intermountain Risk Score with major adverse health events in patients positive for COVID-19: an observational evaluation of a US cohort
Benjamin D Horne, Joseph R Bledsoe, Joseph B Muhlestein, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 18, 2006
A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure
Stephen B Liggett, Jeanne Mialet-Perez, Surai Thaneemit-Chen, et al.
Circulation. Cardiovascular Genetics
|
June 14, 2011
Genome-wide significance and replication of the chromosome 12p11.22 locus near the PTHLH gene for peripartum cardiomyopathy
Benjamin D Horne, Kismet D Rasmusson, Rami Alharethi, et al.
Thrombosis and Haemostasis
|
December 22, 2011
Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy
Benjamin D Horne, Petra A Lenzini, Mia Wadelius, et al.
Nature Communications
|
November 9, 2021
The history and geographic distribution of a KCNQ1 atrial fibrillation risk allele
Shannon Hateley, Angelica Lopez-Izquierdo, Chuanchau J Jou, et al.
Journal of the American College of Cardiology
|
January 29, 2013
Association between the chromosome 9p21 locus and angiographic coronary artery disease burden: a collaborative meta-analysis
Kenneth Chan, Riyaz S Patel, Paul Newcombe, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 84) with videos related to
Sort By:
Page
of 9
JCI Insight
|
July 27, 2018
Extreme erythrocyte macrocytic and microcytic percentages are highly predictive of morbidity and mortality
Benjamin D Horne, Joseph B Muhlestein, Sterling T Bennett, et al.
Circulation. Heart Failure
|
November 3, 2009
An alpha2C-adrenergic receptor polymorphism alters the norepinephrine-lowering effects and therapeutic response of the beta-blocker bucindolol in chronic heart failure
Michael R Bristow, Guinevere A Murphy, Heidi Krause-Steinrauf, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
October 19, 2011
The intermountain risk score predicts incremental age-specific long-term survival and life expectancy
Benjamin D Horne, Joseph B Muhlestein, Donald L Lappé, et al.
Circulation
|
March 21, 2012
A randomized and clinical effectiveness trial comparing two pharmacogenetic algorithms and standard care for individualizing warfarin dosing (CoumaGen-II)
Jeffrey L Anderson, Benjamin D Horne, Scott M Stevens, et al.
BMJ Open
|
March 25, 2022
Association of the Intermountain Risk Score with major adverse health events in patients positive for COVID-19: an observational evaluation of a US cohort
Benjamin D Horne, Joseph R Bledsoe, Joseph B Muhlestein, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 18, 2006
A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure
Stephen B Liggett, Jeanne Mialet-Perez, Surai Thaneemit-Chen, et al.
Circulation. Cardiovascular Genetics
|
June 14, 2011
Genome-wide significance and replication of the chromosome 12p11.22 locus near the PTHLH gene for peripartum cardiomyopathy
Benjamin D Horne, Kismet D Rasmusson, Rami Alharethi, et al.
Thrombosis and Haemostasis
|
December 22, 2011
Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy
Benjamin D Horne, Petra A Lenzini, Mia Wadelius, et al.
Nature Communications
|
November 9, 2021
The history and geographic distribution of a KCNQ1 atrial fibrillation risk allele
Shannon Hateley, Angelica Lopez-Izquierdo, Chuanchau J Jou, et al.
Journal of the American College of Cardiology
|
January 29, 2013
Association between the chromosome 9p21 locus and angiographic coronary artery disease burden: a collaborative meta-analysis
Kenneth Chan, Riyaz S Patel, Paul Newcombe, et al.
Page
of 9